DE2752533C3 - Verfahren zur Herstellung von 10 a -Methoxydihydrolysergol- 5'-bromnicotinsäureester - Google Patents
Verfahren zur Herstellung von 10 a -Methoxydihydrolysergol- 5'-bromnicotinsäureesterInfo
- Publication number
- DE2752533C3 DE2752533C3 DE19772752533 DE2752533A DE2752533C3 DE 2752533 C3 DE2752533 C3 DE 2752533C3 DE 19772752533 DE19772752533 DE 19772752533 DE 2752533 A DE2752533 A DE 2752533A DE 2752533 C3 DE2752533 C3 DE 2752533C3
- Authority
- DE
- Germany
- Prior art keywords
- acid ester
- methoxydihydrolysergol
- preparation
- acid
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 3
- 239000002253 acid Substances 0.000 title description 7
- 150000002148 esters Chemical class 0.000 title description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 8
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- FQIUCPGDKPXSLL-UHFFFAOYSA-N 5-bromopyridine-3-carboxylic acid Chemical compound OC(=O)C1=CN=CC(Br)=C1 FQIUCPGDKPXSLL-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- YCDOKVYDOXHREN-UHFFFAOYSA-N 4-bromopyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CN=CC=C1Br YCDOKVYDOXHREN-UHFFFAOYSA-N 0.000 description 1
- FMDREJRIXNEGEG-UHFFFAOYSA-N 5-bromopyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CN=CC(Br)=C1 FMDREJRIXNEGEG-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| YU312976A YU39278B (en) | 1976-12-22 | 1976-12-22 | Process for preparing 5-bromo nicotinic acid esters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2752533A1 DE2752533A1 (de) | 1978-06-29 |
| DE2752533B2 DE2752533B2 (de) | 1980-01-17 |
| DE2752533C3 true DE2752533C3 (de) | 1980-09-18 |
Family
ID=25559391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772752533 Expired DE2752533C3 (de) | 1976-12-22 | 1977-11-24 | Verfahren zur Herstellung von 10 a -Methoxydihydrolysergol- 5'-bromnicotinsäureester |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5384996A (enExample) |
| DD (1) | DD133665A1 (enExample) |
| DE (1) | DE2752533C3 (enExample) |
| FR (1) | FR2375230A1 (enExample) |
| GB (1) | GB1557506A (enExample) |
| PL (1) | PL107131B1 (enExample) |
| SU (1) | SU645580A3 (enExample) |
| YU (1) | YU39278B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1094965B (it) * | 1978-04-05 | 1985-08-10 | Corvi Mora E | Procedimento di preparazione di derivati del lisergolo |
| JPS5661376A (en) * | 1979-10-09 | 1981-05-26 | Corvi Mora E | Manufacture of lysergol derivative |
| GB2173189B (en) * | 1985-02-21 | 1988-04-27 | Maruko Pharmaceutical Co | Ergoline derivatives and salts thereof and pharmaceutical compositions thereof |
| HU193782B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
| GB8612366D0 (en) * | 1986-05-21 | 1986-06-25 | Erba Farmitalia | Ergoline esters |
| GB9603226D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Heterocyclyl-ergoline derivatives |
| FR2786099B1 (fr) * | 1998-11-24 | 2000-12-29 | Aventis Laboratoire | Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline |
| FR2786101B1 (fr) * | 1998-11-24 | 2002-07-05 | Aventis Laboratoire | Utilisation de la nicergoline dans le traitement de la spasticite |
| JP4845861B2 (ja) * | 2007-11-09 | 2011-12-28 | 興研株式会社 | 使い捨て式防じんマスク |
-
1976
- 1976-12-22 YU YU312976A patent/YU39278B/xx unknown
-
1977
- 1977-11-24 DE DE19772752533 patent/DE2752533C3/de not_active Expired
- 1977-11-30 SU SU772547851A patent/SU645580A3/ru active
- 1977-12-01 DD DD20235277A patent/DD133665A1/xx unknown
- 1977-12-02 JP JP14405277A patent/JPS5384996A/ja active Granted
- 1977-12-06 GB GB5073977A patent/GB1557506A/en not_active Expired
- 1977-12-12 PL PL20287577A patent/PL107131B1/pl unknown
- 1977-12-20 FR FR7738364A patent/FR2375230A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5512909B2 (enExample) | 1980-04-04 |
| SU645580A3 (ru) | 1979-01-30 |
| FR2375230A1 (fr) | 1978-07-21 |
| GB1557506A (en) | 1979-12-12 |
| DD133665A1 (de) | 1979-01-17 |
| YU39278B (en) | 1984-10-31 |
| PL107131B1 (pl) | 1980-01-31 |
| DE2752533A1 (de) | 1978-06-29 |
| JPS5384996A (en) | 1978-07-26 |
| YU312976A (en) | 1982-08-31 |
| FR2375230B1 (enExample) | 1983-01-14 |
| DE2752533B2 (de) | 1980-01-17 |
| PL202875A1 (pl) | 1978-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2718038C2 (de) | Verfahren zur Razemisierung eines Esters einer optisch aktiven Cyclopropancarbonsäure mit einem optisch aktiven α-Cyan-3-phenoxybenzylalkohol zu einem Ester einer optisch aktiven Säure mit dem racemischen α-Cyan-3-phenoxybenzylalkohol | |
| DE2752533C3 (de) | Verfahren zur Herstellung von 10 a -Methoxydihydrolysergol- 5'-bromnicotinsäureester | |
| EP0656896B1 (de) | Neue leukotrien-b4-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE1801750A1 (de) | Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung | |
| DE68905831T2 (de) | Verfahren zur synthese von 3'-azido-3'-deoxythymidin und analoge. | |
| EP0045837A1 (de) | Reaktive Derivate des 3-Oxa-bicyclo(4.3.0)-non-1-en-9-ons, Verfahren zu ihrer Herstellung und deren Verwendung | |
| DE19900172A1 (de) | Verfahren zur Herstellung von L-p-Boronophenylalanin und Zwischenprodukt zur Herstellung desselben | |
| DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2326008A1 (de) | Verfahren zur herstellung von 25hydroxycholesterin und deren ester | |
| DE3000246C2 (de) | Verfahren zur Herstellung von L-α-Glycerylphosphorylcholin | |
| DE4030587C2 (de) | Verfahren zur Herstellung von D-Myoinosit-1-phosphat | |
| DE3207470C2 (enExample) | ||
| DE2611788C2 (de) | Fluorprostaglandine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
| DE2404946C3 (de) | Verfahren zur Herstellung von 7alpha-Acylthio-Steroidspirolactonen | |
| DE2720088C2 (enExample) | ||
| DE2501861C2 (de) | 3,4,6-Tri-O-acyl-2-desoxy-2-nicotinoylamino-1-O-nicotinoyl-β-D-glucopyranosen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
| DE69229017T2 (de) | Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung | |
| DE1092932B (de) | Verfahren zur Herstellung amoebicid wirksamer N-Dichloracet-oxy-anilid-Ester | |
| DE60304484T2 (de) | Verfahren zur herstellung von einem ribofuranose | |
| DE2832857A1 (de) | Verfahren zur herstellung wasserloeslicher hydroxy-flavonaether | |
| DE3317159C2 (enExample) | ||
| DE2833967A1 (de) | Verfahren zur herstellung von apovincamin | |
| DE2857790C2 (de) | Verfahren zur Herstellung von O-geschützten 2-Azido-2-desoxy-glycosylhalogeniden, einige derartige Verbindungen als solche und deren Verwendung | |
| DE1543522C3 (de) | Acylaminophenolalkanole, Verfahren zu ihrer Herstellung und diese Acylaminophenolalkanole enthaltende pharmazeutische Mittel | |
| DE69301345T2 (de) | Verfahren zur Herstellung von 4-Deoxy-D-Mannose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OAP | Request for examination filed | ||
| OD | Request for examination | ||
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |